Timing of supplementation of selenium and isoflavones determines prostate cancer risk factor reduction in rats
2008

Timing of Selenium and Isoflavones Supplementation and Prostate Cancer Risk in Rats

Sample size: 23 publication Evidence: moderate

Author Information

Author(s): Jessica R. Tolman, Edwin D. Lephart, Kenneth D. R. Setchell, Dennis L. Eggett, Merrill J. Christensen

Primary Institution: Brigham Young University

Hypothesis

Does combined supplementation of selenium and isoflavones reduce prostate cancer risk factors in rats more than each component individually?

Conclusion

Combined intake of high selenium and high isoflavones may achieve greater chemopreventive effects than either compound individually.

Supporting Evidence

  • High isoflavone intake significantly reduced body weight in rat pups.
  • Combined high selenium and high isoflavones produced the lowest weight gain in pups.
  • High selenium intake decreased serum IGF-1 levels in pups.

Takeaway

Feeding rats a mix of selenium and isoflavones from birth helps them stay healthier and reduces their risk of prostate cancer.

Methodology

Male Noble rat pups were fed diets with varying levels of selenium and isoflavones from conception until sacrifice at different ages.

Limitations

The study was conducted on rats, which may not fully represent human responses.

Participant Demographics

Male Noble rats

Statistical Information

P-Value

p = 0.001–0.047

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/1743-7075-5-31

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication